SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
2006

Study of SIV Escape Mutants in Vaccinated Rhesus Macaques

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): Villefroy Pascale, Letourneur Franck, Coutsinos Zoe, Mortara Lorenzo, Beyer Christian, Gras-Masse Helene, Guillet Jean-Gerard, Bourgault-Villada Isabelle

Primary Institution: Institut Cochin, Département d'Immunologie, Hôpital Cochin, Paris, France

Hypothesis

Can vaccine-induced CTL responses control the emergence of viral variants in SIV-infected macaques?

Conclusion

The study provides insights into how CD8+ T cell responses can influence the evolution of viral variants after vaccination.

Supporting Evidence

  • Seven out of eight macaques exhibited CD8+ CTL responses after vaccination.
  • High levels of plasma viral RNA were observed in most macaques post-inoculation.
  • One macaque maintained undetectable viral loads after SIV challenge.

Takeaway

Researchers gave a vaccine to 8 monkeys and then exposed them to a virus to see how well the vaccine worked against new virus types. Most monkeys had more virus after exposure, but one monkey did not.

Methodology

Eight rhesus macaques were vaccinated with SIV-NEF and GAG lipopeptides and then challenged with pathogenic SIVmac251 to monitor CTL responses and viral loads.

Limitations

The study primarily focused on a small sample size of macaques, which may limit the generalizability of the findings.

Participant Demographics

All participants were rhesus macaques (Macaca mulatta).

Digital Object Identifier (DOI)

10.1186/1743-422X-3-65

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication